INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 129 filers reported holding INTERSECT ENT INC in Q2 2017. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,958,000 | +130.2% | 355,531 | +124.5% | 0.01% | +700.0% |
| Q4 2021 | $4,326,000 | +40.1% | 158,388 | +39.5% | 0.00% | 0.0% |
| Q3 2021 | $3,088,000 | +534.1% | 113,514 | +297.8% | 0.00% | – |
| Q2 2021 | $487,000 | -92.9% | 28,534 | -91.3% | 0.00% | -100.0% |
| Q1 2021 | $6,841,000 | +61.8% | 327,705 | +77.5% | 0.00% | +100.0% |
| Q4 2020 | $4,228,000 | +660.4% | 184,668 | +441.3% | 0.00% | – |
| Q3 2020 | $556,000 | -82.7% | 34,114 | -85.6% | 0.00% | -100.0% |
| Q2 2020 | $3,216,000 | +61.0% | 237,470 | +40.9% | 0.00% | 0.0% |
| Q1 2020 | $1,997,000 | -86.6% | 168,532 | -71.9% | 0.00% | -75.0% |
| Q4 2019 | $14,930,000 | +52.3% | 599,551 | +4.1% | 0.01% | +33.3% |
| Q3 2019 | $9,800,000 | +38.2% | 576,118 | +84.9% | 0.01% | +20.0% |
| Q2 2019 | $7,091,000 | +80.0% | 311,538 | +154.2% | 0.01% | +66.7% |
| Q1 2019 | $3,940,000 | +856.3% | 122,547 | +738.3% | 0.00% | – |
| Q4 2018 | $412,000 | -72.9% | 14,619 | -72.3% | 0.00% | -100.0% |
| Q3 2018 | $1,518,000 | +113.2% | 52,810 | +177.8% | 0.00% | – |
| Q2 2018 | $712,000 | +195.4% | 19,013 | +210.4% | 0.00% | – |
| Q1 2018 | $241,000 | -71.7% | 6,125 | -76.7% | 0.00% | -100.0% |
| Q4 2017 | $851,000 | +17.1% | 26,258 | +12.6% | 0.00% | 0.0% |
| Q3 2017 | $727,000 | +47.8% | 23,316 | +32.3% | 0.00% | 0.0% |
| Q2 2017 | $492,000 | +69.7% | 17,622 | +4.1% | 0.00% | – |
| Q1 2017 | $290,000 | -96.0% | 16,923 | -97.2% | 0.00% | -100.0% |
| Q4 2016 | $7,264,000 | +11075.4% | 600,303 | +14726.0% | 0.01% | – |
| Q3 2016 | $65,000 | +225.0% | 4,049 | +165.9% | 0.00% | – |
| Q2 2016 | $20,000 | -62.3% | 1,523 | -45.0% | 0.00% | – |
| Q1 2016 | $53,000 | -54.3% | 2,771 | -47.6% | 0.00% | – |
| Q4 2015 | $116,000 | +5700.0% | 5,290 | +6051.2% | 0.00% | – |
| Q3 2015 | $2,000 | -75.0% | 86 | -67.9% | 0.00% | – |
| Q2 2015 | $8,000 | +60.0% | 268 | +48.1% | 0.00% | – |
| Q1 2015 | $5,000 | -86.8% | 181 | -91.5% | 0.00% | – |
| Q4 2014 | $38,000 | – | 2,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |